Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HOXD3 |
| Upstream (Parents) |
|---|
| (<<) HOXD4 → HOXD3 |
| (<<) SOX30 → HOXD3 |
| (<<) MYF6 → HOXD3 |
| (<<) HESX1 → HOXD3 |
| (<<) IRX5 → HOXD3 |
| (<<) TSHZ2 → HOXD3 |
| (<<) NPAT → HOXD3 |
| (<<) T → HOXD3 |
| (<<) RARG → HOXD3 |
| (<<) DLX4 → HOXD3 |
| (<<) ZNF81 → HOXD3 |
| (<<) CBFA2T3 → HOXD3 |
| (<<) SOX18 → HOXD3 |
| (<<) MEF2C → HOXD3 |
| (<<) HOXB1 → HOXD3 |
| (<<) CREBBP → HOXD3 |
| (<<) TCF7 → HOXD3 |
| (<<) CREB5 → HOXD3 |
| (<<) MYOD1 → HOXD3 |
| (<<) BHLHE40 → HOXD3 |
| Downstream (Children) |
|---|
| HOXD3 → HOXD13 (>>) |
| HOXD3 → TP63 (>>) |
| HOXD3 → IRX4 (>>) |
| HOXD3 → HOXA4 (>>) |
| HOXD3 → FUBP1 (>>) |
| HOXD3 → SIX5 (>>) |
